Quarter Period Consolidated Statement Of Income

SHIN NIPPON BIOMEDICAL LABORATORIES, LTD. - Filing #7303041

Concept 2024-04-01 to
2024-09-30
2024-04-01 to
2024-09-30
2024-04-01 to
2024-09-30
2024-04-01 to
2024-09-30
2024-04-01 to
2024-09-30
2024-04-01 to
2024-09-30
2024-04-01 to
2024-09-30
2024-04-01 to
2024-09-30
2023-04-01 to
2023-09-30
2023-04-01 to
2023-09-30
2023-04-01 to
2023-09-30
2023-04-01 to
2023-09-30
2023-04-01 to
2023-09-30
2023-04-01 to
2023-09-30
2023-04-01 to
2023-09-30
2023-04-01 to
2023-09-30
Quarter period consolidated statement of income
Statement of income
Net sales
1,239,022,000 JPY
12,440,439,000 JPY
12,508,481,000 JPY
225,524,000 JPY
12,199,521,000 JPY
13,679,462,000 JPY
-1,170,981,000 JPY
15,393,000 JPY
348,736,000 JPY
11,490,962,000 JPY
12,588,205,000 JPY
11,884,047,000 JPY
-704,157,000 JPY
6,457,000 JPY
742,048,000 JPY
11,846,156,000 JPY
Cost of sales
5,985,140,000 JPY
5,530,749,000 JPY
Gross profit (loss)
6,523,340,000 JPY
6,353,298,000 JPY
Selling, general and administrative expenses
Selling, general and administrative expenses
6,443,312,000 JPY
4,003,818,000 JPY
Operating profit (loss)
60,339,000 JPY
209,283,000 JPY
80,028,000 JPY
-221,186,000 JPY
2,205,960,000 JPY
269,623,000 JPY
-189,594,000 JPY
-1,775,490,000 JPY
-57,265,000 JPY
2,942,714,000 JPY
2,455,787,000 JPY
2,349,479,000 JPY
-106,308,000 JPY
-498,673,000 JPY
69,010,000 JPY
2,386,776,000 JPY
Non-operating income
Interest income
34,913,000 JPY
85,389,000 JPY
Dividend income
850,000 JPY
1,525,000 JPY
Share of profit of entities accounted for using equity method
1,834,943,000 JPY
1,239,850,000 JPY
Non-operating income
1,943,971,000 JPY
1,730,384,000 JPY
Non-operating expenses
Interest expenses
93,994,000 JPY
62,692,000 JPY
Non-operating expenses
194,863,000 JPY
323,408,000 JPY
Ordinary profit (loss)
1,829,136,000 JPY
3,756,455,000 JPY
Extraordinary income
Gain on sale of non-current assets
JPY
3,655,000 JPY
Extraordinary income
21,919,000 JPY
85,819,000 JPY
Extraordinary losses
Loss on sale of non-current assets
JPY
2,581,000 JPY
Impairment losses
9,921,000 JPY
3,165,000 JPY
Extraordinary losses
95,060,000 JPY
28,453,000 JPY
Profit (loss) before income taxes
1,755,995,000 JPY
3,813,821,000 JPY
Income taxes - current
582,136,000 JPY
1,178,999,000 JPY
Income taxes - deferred
-138,684,000 JPY
-338,627,000 JPY
Income taxes
443,451,000 JPY
840,371,000 JPY
Profit (loss)
1,312,543,000 JPY
2,973,450,000 JPY
Profit attributable to
Profit (loss) attributable to non-controlling interests
-18,492,000 JPY
7,281,000 JPY
Profit (loss) attributable to owners of parent
1,331,035,000 JPY
2,966,169,000 JPY
Other comprehensive income
Valuation difference on available-for-sale securities
2,786,264,000 JPY
563,398,000 JPY
Foreign currency translation adjustment
-688,974,000 JPY
3,030,544,000 JPY
Share of other comprehensive income of entities accounted for using equity method
132,298,000 JPY
63,255,000 JPY
Other comprehensive income
2,229,588,000 JPY
3,657,198,000 JPY
Comprehensive income
3,542,132,000 JPY
6,630,648,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
3,563,770,000 JPY
6,625,402,000 JPY
Comprehensive income attributable to non-controlling interests
-21,637,000 JPY
5,246,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.